Patents by Inventor Lorraine Donaghy

Lorraine Donaghy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240083856
    Abstract: The present invention provides crystalline forms of (E)-6-(4-Phenylcyclohexyl)-5-(3-trifluoromethylbenzyl)-1H-pyrimidine-2,4-dione, and methods of making and using the same.
    Type: Application
    Filed: August 7, 2023
    Publication date: March 14, 2024
    Inventors: Hazel Joan Hunt, Lorraine Donaghy, Keith Lorimer, Nathan Jay Dixon, Jeffrey Mark Dener
  • Patent number: 11760731
    Abstract: The present invention provides crystalline forms of (E)-6-(4-Phenylcyclohexyl)-5-(3-trifluoromethylbenzyl)-1H-pyrimidine-2,4-dione, and methods of making and using the same.
    Type: Grant
    Filed: December 5, 2022
    Date of Patent: September 19, 2023
    Assignee: Corcept Therapeutics Incorporated
    Inventors: Hazel Joan Hunt, Lorraine Donaghy, Keith Lorimer, Nathan Jay Dixon, Jeffrey Mark Dener
  • Publication number: 20230212128
    Abstract: The present invention provides crystalline forms of (E)-6-(4-Phenylcyclohexyl)-5-(3-trifluoromethylbenzyl)-1H-pyrimidine-2,4-dione, and methods of making and using the same.
    Type: Application
    Filed: December 5, 2022
    Publication date: July 6, 2023
    Inventors: Hazel Joan Hunt, Lorraine Donaghy, Keith Lorimer, Nathan Jay Dixon, Jeffrey Mark Dener
  • Patent number: 11548856
    Abstract: The present invention provides crystalline forms of (E)-6-(4-Phenylcyclohexyl)-5-(3-trifluoromethylbenzyl)-1H-pyrimidine-2,4-dione, and methods of making and using the same.
    Type: Grant
    Filed: May 5, 2021
    Date of Patent: January 10, 2023
    Assignee: Corcept Therapeutics Incorporated
    Inventors: Hazel Joan Hunt, Lorraine Donaghy, Keith Lorimer, Nathan Jay Dixon, Jeffrey Mark Dener
  • Publication number: 20210363112
    Abstract: The present invention provides crystalline forms of (E)-6-(4-Phenylcyclohexyl)-5-(3-trifluoromethylbenzyl)-1H-pyrimidine-2,4-dione, and methods of making and using the same.
    Type: Application
    Filed: May 5, 2021
    Publication date: November 25, 2021
    Inventors: Hazel Joan HUNT, Lorraine DONAGHY, Keith LORIMER, Nathan Jay DIXON, Jeffrey Mark DENER
  • Patent number: 9458148
    Abstract: Provided is a polymorphic form of Masitinib mesylate, processes for its preparation, compositions comprising it and their medical use.
    Type: Grant
    Filed: December 17, 2014
    Date of Patent: October 4, 2016
    Assignee: SANDOZ AG
    Inventors: Noel Hamill, Lorraine Donaghy
  • Publication number: 20150166524
    Abstract: Provided is a polymorphic form of Masitinib mesylate, processes for its preparation, compositions comprising it and their medical use.
    Type: Application
    Filed: December 17, 2014
    Publication date: June 18, 2015
    Inventors: Noel Hamill, Lorraine Donaghy